HIGHBuilt-inProduct / Revenue mix
robotic systems and single-use disposable handpieces
“10-K Item 1A: 'substantially all of our revenue has been derived...from sales of our robotic systems and our accompanying single-use disposable handpieces'”
PRCT · Concentration risk · 10-K extracted
PROCEPT BioRobotics (PRCT) concentration risks
Updated
The most significant concentration PROCEPT BioRobotics discloses is robotic systems and single-use disposable handpieces, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: PROCEPT BioRobotics’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 1 disclosed concentration
HIGH1
MEDIUM0
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-07-06Procept BioRobotics' revenue base is concentrated by product line rather than by customer or geography: substantially all revenue is derived from sales of its robotic systems and the accompanying single-use disposable handpieces. This is a structural exposure — it reflects the company's business model rather than dependence on any single counterparty, supplier, or region. There is no disclosed customer, geographic, or supplier concentration in the filing to weigh against it. The practical implication is that the company's fortunes are tied almost entirely to continued adoption of the robotic platform and recurring handpiece consumption; any slowdown in procedure volume or system placements would flow directly through revenue with little offsetting diversification. Because this concentration is structural rather than a dependency on a specific customer or single-source input, it is unlikely to create an abrupt shock — it instead defines the shape of the investment case itself: a razor/razorblade model where growth is a function of installed base and utilization rather than a diversified revenue mix. Absent other disclosed exposures, this is the primary lens through which to read the company's concentration profile.
For the engine’s reasoning on PRCT’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Devices
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| AORT | Artivion, Inc. | 4 | 4 | 0 | 8 |
| AVNS | Avanos Medical, Inc. | 2 | 0 | 1 | 3 |
| ATEC | Alphatec Holdings, Inc. | 1 | 1 | 0 | 2 |
| ABT | Abbott Laboratories | 1 | 0 | 0 | 1 |
| PRCT● | PROCEPT BioRobotics Corporation | 1 | 0 | 0 | 1 |
| AHCO | AdaptHealth Corp. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.